Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.260 | 0.260 | 0.000 |
Stocks | 99.740 | 99.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.289 | 21.770 |
Price to Book | 3.281 | 3.989 |
Price to Sales | 3.160 | 2.260 |
Price to Cash Flow | 13.336 | 16.880 |
Dividend Yield | 2.952 | 1.345 |
5 Years Earnings Growth | 8.465 | 11.341 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Merck&Co | US58933Y1055 | 8.08 | 128.42 | +2.29% | |
Novartis | CH0012005267 | 6.53 | 92.73 | -0.47% | |
J&J | US4781601046 | 6.27 | 147.74 | +0.73% | |
Pfizer | US7170811035 | 6.02 | 29.31 | +2.27% | |
Roche Holding Participation | CH0012032048 | 5.60 | 232.10 | +0.48% | |
Eli Lilly | US5324571083 | 4.32 | 831.26 | +1.33% | |
Daiichi Sankyo | JP3475350009 | 4.20 | 5,449.0 | -2.31% | |
Novo Nordisk B | DK0062498333 | 4.07 | 923.9 | -0.37% | |
Moderna | US60770K1079 | 3.86 | 147.82 | +3.70% | |
GSK plc | GB00BN7SWP63 | 3.79 | 1,598.00 | -9.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 716M | 8.56 | 8.67 | 13.08 | ||
Seligson & Co Global Top 25 Brands | 716M | 8.56 | 8.66 | 13.04 | ||
Seligson North American B | 466.52M | 14.56 | 14.20 | 14.73 | ||
Seligson & Co North American A | 466.52M | 14.56 | 14.21 | 14.74 | ||
Seligson & Co Europe Index Fund A | 281.06M | 7.96 | 8.51 | 7.01 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review